Evidence map›Paper›PMID 25253283›Full record

ArticleBMC microbiology2014

Cell death and ultrastructural alterations in Leishmania amazonensis caused by new compound 4-Nitrobenzaldehyde thiosemicarbazone derived from S-limonene.

Elizandra Aparecida Britta, Débora Botura Scariot, Hugo Falzirolli, Tânia Ueda-Nakamura, Cleuza Conceição Silva, Benedito Prado Dias Filho, Redouane Borsali, Celso Vataru Nakamura

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 74 citations in OpenAlex.

  1. Cell Death and Unprecedent Cytoskeletal Changes inChemical & biomedical imaging · 2026
    Article
  2. Article
  3. Review
  4. Sphingosine as a New Antifungal Agent againstInternational journal of molecular sciences · 2022
    Article
  5. Monomethylsulochrin isolated from biomass extract ofFrontiers in cellular and infection microbiology · 2022
    Article
  6. GC-MS screening and antiparasitic action ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Article
  7. Article
  8. Article
  9. Promastigotes ofCurrent research in parasitology & vector-borne diseases · 2021
    Article
  10. Article
  11. Nitro-Heterocyclic compounds induce apoptosis-like effects inThe journal of venomous animals and toxins including tropical diseases · 2019
    Article
  12. Synergistic combination of alkylphosphocholines with peptaibols in targeting Leishmania infantum in vitro.International journal for parasitology. Drugs and drug resistance · 2018
    Article
  13. Induction of Early Autophagic Process onFrontiers in microbiology · 2017
    Article
  14. Acyclic Sesquiterpenes from the Fruit Pericarp ofEvidence-based complementary and alternative medicine : eCAM · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Elizandra Aparecida Britta
Débora Botura Scariot
Hugo Falzirolli
Tânia Ueda-Nakamura
Cleuza Conceição Silva
Benedito Prado Dias Filho
Redouane Borsali
Celso Vataru Nakamura
Universidade Estadual de Maringá · BRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe treatment of leishmaniasis with pentavalent antimonials is problematic because of their toxicity. Investigations of potentially active molecules are important to discover less toxic drugs that are viable economic alternatives for the treatment of leishmaniasis. Thiosemicarbazones are a group of molecules that are known for their wide versatility and biological activity. In the present study, we examined the antileishmania activity, mechanism of action, and biochemical alterations produced by a novel molecule, 4-nitrobenzaldehyde thiosemicarbazone (BZTS), derived from S-limonene against Leishmania amazonensis.

resultsBZTS inhibited the growth of the promastigote and axenic amastigote forms, with an IC50 of 3.8 and 8.0 μM, respectively. Intracellular amastigotes were inhibited by the compound with an IC50 of 7.7 μM. BZTS also had a CC50 of 88.8 μM for the macrophage strain J774A1. BZTS altered the shape, size, and ultrastructure of the parasites, including damage to mitochondria, reflected by extensive swelling and disorganization of the inner mitochondrial membrane, intense cytoplasmic vacuolization, and the presence of concentric membrane structures inside the organelle. Cytoplasmic lipid bodies, vesicles inside vacuoles in the flagellar pocket, and enlargement were also observed. BZTS did not induce alterations in the plasma membrane or increase annexin-V fluorescence intensity, indicating no phosphatidylserine exposure. However, it induced the production of mitochondrial superoxide anion radicals.

conclusionsThe present results indicate that BZTS induced dramatic effects on the ultrastructure of L. amazonensis, which might be associated with mitochondrial dysfunction and oxidative damage, leading to parasite death.

Indexed as

AnimalsAntiprotozoal AgentsBenzaldehydesCell DeathCell LineCell SurvivalCyclohexenesInhibitory Concentration 50Leishmania mexicanaLimoneneMacrophagesMiceOrganellesParasitic Sensitivity TestsTerpenesThiosemicarbazones4-nitrobenzaldehydeAntiprotozoal AgentsBenzaldehydesCyclohexenesLimoneneTerpenesThiosemicarbazones

Identifiers

PMID25253283
PMCPMC4188478
OpenAlexW2074348292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.